Trial Profile
Assessment of Brain Kappa Opioid Receptor Occupancy After Single Oral Doses of LY2456302 as Measured by PET With Radioligand LY2879788 in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Aticaprant (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 05 May 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 05 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jan 2011 Planned end date changed from Mar 2011 to May 2011 as reported by ClinicalTrials.gov.